[ad_1] Viking Therapeutics Inc.’s stock soared 100% early Tuesday, after the company announced positive results…
Obesity
-
-
STOCK MARKET
Amgen’s quarterly results top expectations despite Enbrel sales decline
by userby user[ad_1] Amgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts’ expectations even as…
-
[ad_1] When Betsy Price was mayor of Fort Worth, Texas, she wanted to tackle childhood…
-
STOCK MARKET
What is Wegovy worth to your employer? Companies wrestle with obesity drugs’ costs, long-term value.
by userby user[ad_1] Amid mounting evidence of obesity drugs’ longer-term health benefits, thorny questions persist about their…
-
STOCK MARKET
Eli Lilly launches home delivery of obesity drug Zepbound, warns on cosmetic use
by userby user[ad_1] Eli Lilly & Co. on Thursday announced the launch of new digital health services…
-
STOCK MARKET
4 things the best diets of 2024 have in common — and where Ozempic and Wegovy fit in
by userby user[ad_1] Losing weight is one of the top New Year’s resolutions that people make year…
-
STOCK MARKET
Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk?
by userby user[ad_1] The obesity drugs that powered huge investor gains in 2023 are poised to inspire…
-
STOCK MARKET
What’s the best way to lose weight? ‘It’s everything,’ Oprah says — and experts agree.
by userby user[ad_1] If you want to follow Oprah Winfrey’s latest plan for losing weight, be prepared…
-
STOCK MARKET
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
by userby user[ad_1] Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion,…
-
STOCK MARKET
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
by userby user[ad_1] Pfizer Inc.’s stock tumbled 4% premarket Friday, after the company said it would not…